| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 06/12/2013 | CN102399820B Small interfering RNA directed at HPV16 E7 gene and its application |
| 06/12/2013 | CN102266566B Magnetic compound, and preparation method and purpose thereof |
| 06/12/2013 | CN102140465B Human miR-1249 antisense nucleic acid and application thereof |
| 06/12/2013 | CN102140462B Human miR-1260 antisense nucleic acid and application thereof |
| 06/12/2013 | CN102031255B Antisense nucleic acid of human miR-223 and applications of antisense nucleic acid |
| 06/12/2013 | CN102002489B MicroRNA for inhibiting multiplication of H1N1 influenza virus and application thereof |
| 06/12/2013 | CN101906418B Promoter for introducing gene into lymphocyte or blood cell and application thereof |
| 06/12/2013 | CN101875931B siRNA recombinant slow virus for inhibiting human hephaestin gene expression and application |
| 06/11/2013 | US8461321 Nucleic acids encoding a deletion variant of uPAR |
| 06/11/2013 | US8461313 Conjugates and compositions for cellular delivery |
| 06/11/2013 | US8461309 Inhibitor protein of the wnt signal pathway |
| 06/11/2013 | US8461127 p27 and p21 in gene therapies |
| 06/11/2013 | US8460933 Expression system incorporating a capsid promoter sequence as an enhancer |
| 06/11/2013 | US8460932 Method of treating a disorder by suicide gene therapy |
| 06/11/2013 | US8460931 Neural progenitor cells derived from embryonic stem cells |
| 06/11/2013 | US8460678 Use of triplex structure DNA in transferring nucleotide sequences |
| 06/11/2013 | CA2559161C Irna agents targeting vegf |
| 06/11/2013 | CA2498004C Compositions and methods for the diagnosis and treatment of tumor |
| 06/11/2013 | CA2437942C Chimeric molecules to modulate gene expression |
| 06/11/2013 | CA2407959C Human wingless-like gene |
| 06/11/2013 | CA2407603C Porphyromonas gingivalis recombinant proteins and truncations |
| 06/11/2013 | CA2406839C G-protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same |
| 06/11/2013 | CA2388461C Highly conserved genes and their use to generate probes and primers for the detection of microorganisms |
| 06/11/2013 | CA2377381C Neovascular-targeted immunoconjugates |
| 06/11/2013 | CA2267664C Human telomerase reverse transcriptase |
| 06/11/2013 | CA2229307C Circular dna molecule with conditional origin of replication, method for preparing same and use thereof in gene therapy |
| 06/06/2013 | WO2013082543A1 Mesenchymal stromal cells and uses related thereto |
| 06/06/2013 | WO2013082515A2 Nucleic acid aptamers directed to surface receptors and methods of use |
| 06/06/2013 | WO2013082449A2 Treatment of b cell lymphomas |
| 06/06/2013 | WO2013052965A3 Control of whole body energy homeostasis by microrna regulation |
| 06/06/2013 | WO2013034989A3 Microrna-based methods and assays for osteosarcoma |
| 06/06/2013 | WO2013033407A3 Identification of small molecules that enhance therapeutic exon skipping |
| 06/06/2013 | WO2013019623A3 Methods and compositions for modulating the innate immune response and/or myogenesis in a mammalian subject |
| 06/06/2013 | WO2013008881A9 Ischemic disease therapeutic agent |
| 06/06/2013 | WO2012177903A4 Methods of treating cognitive impairment |
| 06/06/2013 | US20130144048 Therapeutic compositions |
| 06/06/2013 | US20130143955 Cyclic di-GMP-II Riboswitches, Motifs, and Compounds, and Methods for Their Use |
| 06/06/2013 | US20130143954 Recombinant vector for suppressing proliferation of human papilloma virus cells including adenylate cyclase activating polypeptide 1 (pituitary) gene and pharmaceutical composition for treating human papilloma virus |
| 06/06/2013 | US20130143953 Compositions, kits and methods for treatment of complement-related disorders |
| 06/06/2013 | US20130143950 Compounds and Methods for the Treatment of Cancer |
| 06/06/2013 | US20130143944 Chemo- and radiation-sensitization of cancer by antisense trpm-2 oligodeoxynucleotides |
| 06/06/2013 | US20130143281 Chimeric PUFA Polyketide Synthase Systems and Uses Thereof |
| 06/06/2013 | US20130142861 Compositions And Method For Detecting And Treating Abnormal Liver Homeostasis And Hepatocarcinogenesis |
| 06/06/2013 | US20130142818 Complexation of nucleic acids with disulfide-crosslinked cationic components for transfection and immunostimulation |
| 06/06/2013 | US20130142764 Methods and compositions for treating brain diseases |
| 06/06/2013 | US20130142760 Atherosclerosis inhibition via modulation of monocyte-macrophage phenotype using apo a-i milano gene transfer |
| 06/06/2013 | CA2857747A1 Treatment of b cell lymphomas |
| 06/06/2013 | CA2857545A1 Mesenchymal stromal cells and uses related thereto |
| 06/05/2013 | EP2599868A1 NUCLEIC ACID MOLECULE CAPABLE OF BINDING TO c-Met AND USE THEREOF |
| 06/05/2013 | EP2599489A1 AChE antisense deoxyoligonucleotide as an anti-inflammatory agent |
| 06/05/2013 | EP2598173A2 Vaccines against pregnancy-associated malaria |
| 06/05/2013 | CN1798545B Method for improving stability and shelf-life of liposome complexes |
| 06/05/2013 | CN103140581A Retrovirus detection |
| 06/05/2013 | CN103140235A Method for predicting a therapy response in subjects with multiple sclerosis |
| 06/05/2013 | CN103131710A ShRNA (short hairpin ribonucleic acid) for inhibiting tumor cell invasion |
| 06/05/2013 | CN103131708A Si ribonucleic acid (RNA) and application thereof |
| 06/05/2013 | CN103131707A Si ribonucleic acid (RNA) and application thereof |
| 06/05/2013 | CN103131706A Si ribonucleic acid (RNA) and application thereof |
| 06/05/2013 | CN103131705A Si ribonucleic acid (RNA) and application thereof |
| 06/05/2013 | CN103131704A Si ribonucleic acid (RNA) and application thereof |
| 06/05/2013 | CN103131703A Si ribonucleic acid (RNA) and application thereof |
| 06/05/2013 | CN103131702A Si ribonucleic acid (RNA) and application thereof |
| 06/05/2013 | CN103130877A Human immunodeficiency virus type I Tat protein mutant 1-37-site sequence and application thereof |
| 06/05/2013 | CN103127528A Application of human Doublecortin (DCX) gene in preparation of glioma radiotherapy sensitizer |
| 06/05/2013 | CN103127492A Anti-hepatitis C virus protein and application thereof |
| 06/05/2013 | CN102703452B siRNA double-strand for inhibiting Bcl2 gene expression and application thereof |
| 06/05/2013 | CN102608333B Tuberculosis diagnostic composition and application thereof |
| 06/05/2013 | CN102392031B Schistosoma japonicum thioredoxin glutathione reductase gene and DNA (deoxyribonucleic acid) vaccine thereof |
| 06/05/2013 | CN102382833B siRNAs (small interfering ribonucleic acids) for suppressing expression of PAR-1 (proteinase activated receptor-1) genes and application thereof |
| 06/05/2013 | CN102337266B siRNAs and recombinant vector for inhibiting expression of Nogo A, MAG and OMgp genes, and application of siRNAs and recombinant vector |
| 06/05/2013 | CN102337251B Chimaera for HK97 bacteriophage virus-like particle and application of chimaera |
| 06/05/2013 | CN102294025B Compound of prostate stem cell antigen polypeptide and nucleic acid and preparation method and application thereof |
| 06/05/2013 | CN102276725B Cryptosporidium CTL and Th mixed multi-epitope gene and fusion protein and application |
| 06/05/2013 | CN102219847B Defensin mNP-1 and applications thereof in preparing anti-influenza virus drugs |
| 06/05/2013 | CN102174550B Recombinant ubiquitin ligase PTB-U-box fusion gene and expression vector and application thereof |
| 06/05/2013 | CN101954077B Expression plasmid adjuvant for enhancing chemotherapeutic effect of tumor chemotherapeutics and preparation method thereof |
| 06/05/2013 | CN101914564B Fusion of multiple enterotoxin genes of escherichia coli and application thereof |
| 06/05/2013 | CN101863964B Helicobacter pylori urease B antigen epitope polypeptide and application thereof |
| 06/05/2013 | CN101654672B RNA interference mediating small RNA molecules |
| 06/05/2013 | CN101596308B ITGB4BP and derivates thereof used for preventing and/or treating hypertrophic scar and fibrosis lesion |
| 06/05/2013 | CN101516908B Nucleic acids for expressing a polynucleotide of interest in mammalian cancer cells |
| 06/05/2013 | CN101460624B Sense oligonucleotide capable of controlling the expression of iNOS and composition comprising the same |
| 06/04/2013 | US8455538 Augmented cognitive training |
| 06/04/2013 | US8455454 miR 204, miR 211, their anti-miRs, and therapeutic uses of same |
| 06/04/2013 | US8455453 Use of VEGF-D gene to prevent restenosis |
| 06/04/2013 | US8455191 Cell transdifferentiation into brown adipocytes |
| 06/04/2013 | US8454976 Recombinant toxin fragments |
| 06/04/2013 | US8454937 Method and composition for the site-selective delivery using viruses encapsulated in microbubbles |
| 06/04/2013 | CA2551022C Polyethyleneglycol-modified lipid compounds and uses thereof |
| 06/04/2013 | CA2432301C Lentiviral vector-mediated gene transfer and uses thereof |
| 06/04/2013 | CA2228667C Antagonists of the oncogenic activity of the protein mdm2, and use thereof in the treatment of cancers |
| 05/30/2013 | WO2013078316A1 Recombinant adeno-associated virus delivery of alpha-sarcoglycan polynucleotides |
| 05/30/2013 | WO2013077228A1 Impdh inhibitor having microrna as active component |
| 05/30/2013 | WO2013076726A1 Stem cell-derived neural cells for cell therapy in neurological disorders |
| 05/30/2013 | WO2013076374A1 Recombinant serotype 5 (ac!5) adenoviral vectors |
| 05/30/2013 | WO2013076262A1 Method for prevention of colectomy |
| 05/30/2013 | WO2013075630A1 Nano particles of nucleic acid and preparation process and use thereof, and three-head single chain nucleic acid unit |
| 05/30/2013 | WO2013022092A9 Heptamer-type small guide nucleic acid capable of inducing apoptosis of human hematologic cancer cells |
| 05/30/2013 | WO2013012806A3 Protection of cells from alu-rna-induced degenereation and inhibitors for protecting cells |
| 05/30/2013 | US20130137758 Akt activity specifically inhibiting polypeptide |